These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 12526990)

  • 1. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.
    Volk DW; Lewis DA
    Physiol Behav; 2002 Dec; 77(4-5):501-5. PubMed ID: 12526990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia.
    Woo TU; Whitehead RE; Melchitzky DS; Lewis DA
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5341-6. PubMed ID: 9560277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.
    Stan AD; Lewis DA
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1557-62. PubMed ID: 22283765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects.
    Pierri JN; Chaudry AS; Woo TU; Lewis DA
    Am J Psychiatry; 1999 Nov; 156(11):1709-19. PubMed ID: 10553733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA; Pierri JN; Volk DW; Melchitzky DS; Woo TU
    Biol Psychiatry; 1999 Sep; 46(5):616-26. PubMed ID: 10472415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schizophrenia and cortical GABA neurotransmission].
    Hashimoto T; Matsubara T; Lewis DA
    Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chandelier neuron in schizophrenia.
    Lewis DA
    Dev Neurobiol; 2011 Jan; 71(1):118-27. PubMed ID: 21154915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia.
    Lewis DA
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):270-6. PubMed ID: 10719153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia.
    Volk DW; Pierri JN; Fritschy JM; Auh S; Sampson AR; Lewis DA
    Cereb Cortex; 2002 Oct; 12(10):1063-70. PubMed ID: 12217970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
    Lewis DA; Volk DW; Hashimoto T
    Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex.
    Cruz DA; Eggan SM; Lewis DA
    J Comp Neurol; 2003 Oct; 465(3):385-400. PubMed ID: 12966563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
    Volk DW; Austin MC; Pierri JN; Sampson AR; Lewis DA
    Arch Gen Psychiatry; 2000 Mar; 57(3):237-45. PubMed ID: 10711910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia.
    Hashimoto T; Volk DW; Eggan SM; Mirnics K; Pierri JN; Sun Z; Sampson AR; Lewis DA
    J Neurosci; 2003 Jul; 23(15):6315-26. PubMed ID: 12867516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
    Lewis DA; Hashimoto T; Morris HM
    Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations.
    Lewis DA; Moghaddam B
    Arch Neurol; 2006 Oct; 63(10):1372-6. PubMed ID: 17030651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia.
    Cruz DA; Weaver CL; Lovallo EM; Melchitzky DS; Lewis DA
    Neuropsychopharmacology; 2009 Aug; 34(9):2112-24. PubMed ID: 19322171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.
    Guidotti A; Auta J; Davis JM; Dong E; Grayson DR; Veldic M; Zhang X; Costa E
    Psychopharmacology (Berl); 2005 Jul; 180(2):191-205. PubMed ID: 15864560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the terminations of GABAergic chandelier cell axons on initial segments of pyramidal cell axons in the monkey sensory-motor cortex.
    DeFelipe J; Hendry SH; Jones EG; Schmechel D
    J Comp Neurol; 1985 Jan; 231(3):364-84. PubMed ID: 2981907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional specificity of chandelier neuron axon terminal alterations in schizophrenia.
    Konopaske GT; Sweet RA; Wu Q; Sampson A; Lewis DA
    Neuroscience; 2006; 138(1):189-96. PubMed ID: 16337746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.